Health Care PRICE Transparency Act

Clarify or reform the 340B program Patient access of plasma therapies Global pharmaceutical supply chain operations and manufacturing locations Most Favored Nation/International Reference Pricing Co-pay accumulators maximizers, alternate funding models Amending P.L. 97-414, Orphan Drug Act Promoting the Congressional Plasma Caucus Rare disease diagnosis and access to care Senate Finance Committee PBM Framework Paper Pharmacy Benefit Managers (PBMs) S. 2973 Modernizing and Ensuring PBM Accountability (MEPA) Act Drug pricing, including House and Senate draft bills S. 652/H.R. 2630, Safe Step Act - provisions related to step therapy policy H.R. 2534, PROTECT 340B Act of 2023 S. 2333, Pandemic and All-Hazards Preparedness and Response Act H.R. 410, S.1130, Health Care PRICE Transparency Act H.R. 830, S.1375, HELP Co-Pays Act H.R.1613, S.1038, Drug Price Transparency in Medicaid Act of 2023 H.R. 2670, S. 2226, National Defense Authorization Act H.R. 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act (IRA commercial spillover) H.R. 5539, Orphan Cures Act H.R. 2679, Pharmacy Benefits Manager Accountability Act - Issues related to tranparency and data disclusure for PBMs H.R. 2816, The PBM Sunshine and Accountability Act H.R. 2880, Protecting Patients Against PBM Abuses Act S. 127, Pharmacy Benefit Manager Transparency Act S.1131, Drug Price Transparency Act of 2023 S.1339, Pharmacy Benefit Manager Reform Act S. 4293, Pharmacy Benefit Manager Transparency Act of 2022 P.L. 111-148, Patient Protection and Affordable Care Act H.R. 5378 -The Lower Costs, More Transparency Act S. 2973 -Modernizing and Ensuring PBM Accountability Act Issues related to dengue vaccines HR 6283 Delinking Revenue from Unfair Gouging "DRUG Act" E.O. 14017, America's Supply Chains E.O. 14087, Lowering Prescription Drug Costs for Americans - issues related to CMMI modeling R.F.I. Docket Number 230831-0207, Document Number 2023-26930, Request for Information Regarding the Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights

Client expense: $510,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

issues relating to hospitals and healthcare H.R.1129 To direct the Secretary of Health and Human Services to revise regulations to remove the requirement under the Medicare program that an off-campus facility or organization shall be located within a 35-mile radius of a hospital or critical access hospital; S.468 Hospital Transparency Compliance Enforcement Act; H.R.990,S 407 SAFE Hospitals Act of 2023; H.R.1565 Critical Access Hospital Relief Act of 2023; H.R.2530 & S1113 Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act; H.R.977-S.470 Patient Access to Higher Quality Health Care Act of 2023; H.R.1475 Hospital Adoption Education Act of 2023; H.R.410 Health Care PRICE Transparency Act; H.R.3417 FAIR Act; HR 2859 Holding Nonprofit Hospitals Accountable Act; H.R.5007, S2657 GREEN Hospitals Act.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to patient access of plasma therapies; P.L. 111-148, Patient Protection and Affordable Care Act; Discussions to clarify or reform the 340B program; Proposals related to drug pricing, including House and Senate draft bills; Discussions related to co-pay accumulators; maximizers, alternate funding models; Discussions related to amending P.L. 97-414, Orphan Drug Act; Issues related to global pharmaceutical supply chain operations and manufacturing locations; HHS/FDA Safe Importation Action Plan - provisions related to the importation of prescription drugs; S. 652/H.R. 2630, Safe Step Act - provisions related to step therapy policy; S. 4293, Pharmacy Benefit Manager Transparency Act of 2022; H.R. 2679, Pharmacy Benefits Manager Accountability Act - Issues related to tranparency and data disclusure for PBMs; H.R.1613, S.1038, Drug Price Transparency in Medicaid Act of 2023; S.1339, Pharmacy Benefit Manager Reform Act; H.R. 2880, Protecting Patients Against PBM Abuses Act; HR 2816, The PBM Sunshine and Accountability Act; S. 1217, Ending the Prescription Drug Kickback Act of 2023; H.R. 2534, PROTECT 340B Act of 2023; S.1131, Drug Price Transparency Act of 2023; S. 127, Pharmacy Benefit Manager Transparency Act; S.113, Prescription Pricing for the People Act; Modernizing and Ensuring PBM Accountability (MEPA) Act H.R.410, S.1130, Health Care PRICE Transparency Act; H.R. 830, S.1375, HELP Co-Pays Act; Issues/Discussions related to Senate Finance Committee PBM Framework Paper; Issues/Discussions related to Pharmacy Benefit Managers (PBMs); Discussions on Customs Border Protection changes impacting southern border plasma collections; Promoting the Congressional Plasma Caucus; Issues related to Dengue vaccines; Discussions related to rare disease diagnosis and access to care; H.R. 2670, S. 2226, National Defense Authorization Act; H.R. 5391, S. 2764, Protecting Patient Access to Cancer and Complex Therapies Act; H.R. 5539, Orphan Cures Act;

issues relating to hospitals and healthcare H.R.1129 To direct the Secretary of Health and Human Services to revise regulations to remove the requirement under the Medicare program that an off-campus facility or organization shall be located within a 35-mile radius of a hospital or critical access hospital; S.468 Hospital Transparency Compliance Enforcement Act; H.R.990,S 407 SAFE Hospitals Act of 2023; H.R.1565 Critical Access Hospital Relief Act of 2023; H.R.2530 & S1113 Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act; H.R.977-S.470 Patient Access to Higher Quality Health Care Act of 2023; H.R.1475 Hospital Adoption Education Act of 2023; H.R.410 Health Care PRICE Transparency Act; H.R.3417 FAIR Act; HR 2859 Holding Nonprofit Hospitals Accountable Act; H.R.5007, S2657 GREEN Hospitals Act.

Client expense: Not reported · Firm income: $15,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

issues relating to hospitals and healthcare H.R.1129 To direct the Secretary of Health and Human Services to revise regulations to remove the requirement under the Medicare program that an off-campus facility or organization shall be located within a 35-mile radius of a hospital or critical access hospital; S.468 Hospital Transparency Compliance Enforcement Act; H.R.990 SAFE Hospitals Act of 2023; H.R.1565 Critical Access Hospital Relief Act of 2023; H.R.2530 & S1113 Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act; H.R.977-S.470 Patient Access to Higher Quality Health Care Act of 202323; H.R.1475 Hospital Adoption Education Act of 2023; H.R.410 Health Care PRICE Transparency Act; H.R.3417 FAIR Act; HR 2859 Holding Nonprofit Hospitals Accountable Act; HR 407 SAFE Hospitals Act of 2023.

Client expense: Not reported · Firm income: $15,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Affordable Care Act, Extending ARPA Subsidies, Individual Market Reform, Behavioral Health (S. 923), Health Equity, Maternal Health, Implementation of No Surprises Act, Health IT, Interoperability, Value-Based Care, Health Care Innovation, COVID-19 PHE Transition (Medicaid Redeterminations, Commercialization of COVID-19 Vaccines & Therapeutics), HIPAA and Privacy, Telehealth, Public Option, Pharmacy Benefit Managers (S. 113, S. 127), Insulin Affordability (S. 146, S. 954, S. 727, H.R. 1485), Transparency (H.R. 410, S. 1130), Affordability (site neutral payment policies)

Client expense: $590,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

issues relating to hospitals and healthcare H.R.1129 To direct the Secretary of Health and Human Services to revise regulations to remove the requirement under the Medicare program that an off-campus facility or organization shall be located within a 35-mile radius of a hospital or critical access hospital; S.468 Hospital Transparency Compliance Enforcement Act; H.R.990 SAFE Hospitals Act of 2023; H.R.1565 Critical Access Hospital Relief Act of 2023; H.R.2530 & S1113 Nurse Staffing Standards for Hospital Patient Safety and Quality Care Act; H.R.977-S.470 Patient Access to Higher Quality Health Care Act of 202323; H.R.1475 Hospital Adoption Education Act of 2023; H.R.410 Health Care PRICE Transparency Act;

Client expense: Not reported · Firm income: $15,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE